Form 4: UnitedHealth Group Director Paul R. Garcia Reports Changes in Beneficial Ownership

Director Paul R. Garcia reports acquisition of UnitedHealth Group common stock and deferred stock units as part of regular quarterly compensation.

Summary

• Paul R. Garcia, a director of UnitedHealth Group, filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
• On July 1, 2024, Garcia acquired 114 deferred stock units and 64 shares of common stock as quarterly compensation for his service as a director.
• The deferred stock units are immediately vested but must be retained until Garcia completes his service on the Board.
• Following these transactions, Garcia directly owns 1,896 shares of common stock and indirectly owns 2,146 shares through a revocable trust, 30 shares through Trust 1, 45 shares through Trust 2, and 55 shares through Trust 3.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing detailing director compensation, which is generally neutral to slightly positive as it reflects ongoing commitment and alignment of interests.

Positives

• The acquisition of stock and deferred stock units reflects ongoing compensation for Garcia's role as a director.
• The deferred stock units are immediately vested, indicating a long-term commitment to the company.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash, stock, and deferred stock units.
• The specifics of Garcia's compensation are typical for directors of large, publicly traded companies like UnitedHealth Group.
• Comparing Garcia's holdings and compensation structure to those of directors at similar healthcare companies (e.g., CVS Health, Anthem) would provide further context.

Stakeholder Impact

• The filing provides transparency to shareholders regarding director compensation and ownership.
• It assures stakeholders that directors have a vested interest in the company's success.

Key Dates